Zusammenfassung
Auf Grund der Erfahrungen mit Pferdeantihundelymphocytenseren wurden Immunseren vom Pferd gegen menschliche Lymphocyten hergestellt. 7 Pferde wurden bisher immunisiert: 4 mit Lymphocyten aus der Lymphe des Ductus thoracicus, je 1 Pferd mit Lymphocyten von Patienten mit Lymphadenose, mit Milzzellen und mit Thymushomogenaten. In vivo wurden bisher Seren gegen Ductus thoracicus-Lymphocyten und leukämische Lymphocyten erprobt. Einzelheiten der Antigengewinnung, Immunisierung und Präparation der Immunseren werden geschildert. Nach der in vitro-Testung im Leukoagglutinationstest, dessen Problematik geschildert wird, liegen die erreichten Titerhöhen zwischen 1:2000–1:64000.
Summary
Basing on the experiences with horse-antidog-lymphocytesera immunsera from horse against human lymphatic cells have been produced. 7 horses have been immunized: 4 with thoracic duct lymphocytes, each one with lymphocytes from blood of patients suffering from lymphadenosis, with spleen cells and with thymushomogenates. Up to now immunsera against thoracic duct lymphocytes and leucemic lymphocytes have been used in vivo. Details of the preparation of antigens, of immunization and purification of immunsera are described. The leucoagglutinating titer of the immunsera ranged between 1:2000–1:64000. The problems of the in vitro testing are discussed.
Literatur
Anderson, N. F., K. James, andM. F. A. Woodruff: Effect of antilymphocytic antibody and antibody fragments on skin homograft survival and the blood lymphocyte count in rats. Lancet1967I, 1126.
Antoine, B., andJ. Hamburger: Analysis of hydrosoluble tissue antigens. Ann. N. Y. Acad. Sci.129 (1), 14 (1966).
Antoine, B., T. Neveu etJ. F. Bach: Activité immuno-précipitante de divers serums antilymphocytes. Comparison avec d'autres effects. I. Int. Congr. of the Transplantation Society, Paris 1967. Progr. Transplantation (1967) (in press).
Aster, R., H. Cooper, andD. Singer: Simplified complementfixation test for the detection of platelet antibodies in human serum. J. Lab. clin. med.63, 161 (1964).
Backhausz, R.: Immunodiffusion und Immunoelektrophorese, S. 358. Jena: Gustav Fischer 1967.
Bekkum, D. W. van, G. D. Ledney, H. Balner, L. M. van Putten, andM. J. de Vries: Suppression of secondary disease following foreign bone marrow grafting with antilymphocyte serum. In:G. E. W. Wolstenholme andM. O'Connor, Antilymphocytic serum. Ciba Foundation Study Group No 29, p. 97. London: Churchill 1967.
Boak, J. L., M. Fox, andR. E. Wilson: Activity of lymphoid tissues from antilymphocyte-serum-treated mice. Lancet1967I, 750.
Brendel, W., u.R. Pichlmayr: Heterologe Antilymphozytenseren zur Immunsuppression bei Organtransplantationen. Dtsch. med. Wschr.92, 549 (1967).
Currey, H. L. F., andM. Ziff: Suppression of experimentally induced polyarthritis in the rat by heterologous antilymphocyte serum. Lancet1966II, 889.
Denman, A. M., E. J. Denman, andE. J. Holborow: Suppression of Coombspositive haemolytic anaemia in NZB mice by antilymphocyte globulin. Lancet1967I, 1084.
Fateh-Moghadam, A., R. Pichlmayr, H. W. Jarosch von Schweder u.M. Knedel: Isolierung immunologisch wirksamer γ-Globuline eines Pferdeantihundelymphozytenserums. Klin. Wschr.45, 578 (1967).
Fateh-Moghadam, A. R. Pichlmayr, Ch. Morell u.M. Knedel: Verhalten der Immunglobuline und der Antikörperbildung während der Behandlung mit heterologem Anti-lymphozytenserum. Klin. Wschr.45, 665 (1967).
Gray, J. G., M. L. Wood, andP. S. Russell: Studies on heterologous anti-lymphocyte serum in mice. I. In vitro and in vivo properties. J. Immunol.96, 217 (1966).
Graesbeck, R., C. Nordman, andA. de la Chapelle: Mitogenic action of antileucocyte immune serum on peripheral leucocytes in vitro. Lancet1963II, 385.
Guttmann, R. D., C. R. Carpenter, R. R. Lindquist, andJ. P. Merill: Studies of heterologous anti-thymocyte anti-body and its pepsin digestion product. I. Int. Congr. of the Transplantation Society, Paris 1967. Progr. Transplantation (1967) (in press).
Inderbitzin, T.: The relationship of lymphocytes, delayed cutaneous allergic reactions and histamine. Int. Arch. Allergy8, 150 (1956).
Iwasaki, Y., K. A. Porter, J. R. Amend, Th. L. Marchioro, V. Zuehlke, andTh. E. Starzl: The preparation and testing of horse anti-dog and antihuman antilymphoid plasma or serum and its protein fractions. Surg. Gynec. Obstet.124, 1 (1967).
Jeejeebhoy, H. F.: Studies on the mode of action of heterologous anti-lymphocyte plasma. I. A comparison of the immunosuppressive properties of dog and rabbit anti-rat lymphocyte plasma. Transplantation5, 273 (1967).
Kabat, E., andM. Mayer: Experimental immunochemistry, p. 150. Springfield (Ill.) 1964.
Lance, E. M.: The nature and scope of action of heterologous antisera. Symposion on “Cell-bound immunity”, Liège 1967 (in press).
Lance, E. M., andD. W. Dresser: Antigenicity in mice of antilymphocyte gamma globulin. Nature (Lond.)215, 488 (1967).
Levey, R. H., andP. B. Medawar: Nature and mode of action of antilymphocytic antiserum. Proc. nat. Acad. Sci. (Wash.)56, 1130 (1966).
Levey, R. H., andP. B. Medawar: Further experiments on the action of antilymphocytic antiserum. Proc. nat. Acad. Sci. (Wash.)58, 470 (1967).
Ling, N. R., S. Knight, D. Hardy, D. R. Stanworth, andP. J. L. Holt: Antibody induced lymphocyte transformation in vitro. In:G. E. W. Wolstenholme andM. O'Connor, Antilymphocytic serum, CIBA Foundation Study Group No. 29, p. 41. London: Churchill 1967.
Monaco, A. P., W. M. Abott, H. B. Ottersen, R. L. Simons, M. L. Wood, M. H. Flax, andP. S. Russell: Antiserum to lymphocytes: Prolonged survival of canine renal homograft. Science153, 1264 (1966).
Monaco, A. P., M. L. Wood, B. A. van der Werf, andP. S. Russell: Effects of antilymphocyte serum in mice, dogs and man. In:G. E. W. Wolstenholme andM. O'Connor, Antilymphocytic serum, Ciba Foundation Study Group No. 29, p. 111. London: Churchill 1967.
Neiders, M. E., D. A. Rowley, andF. W. Fitch: The sustained suppression of hemolysin response in passively immunized rats. J. Immunol.88, 718 (1962).
Pichlmayr, R.: Wirkung eines heterologen Antilymphozytenserums auf die Transplantatabstoßung beim Hund. Klin. Wschr.44, 594 (1966).
Pichlmayr, R.: Herstellung und Wirkung heterologer Antihundelymphozytenseren. Z. ges. exp. Med.143, 161 (1967).
Pichlmayr, R., W. Brendel u.I. Pichlmayr: Die immunsuppressive Wirkung eines heterologen Antihundelymphozytenserums. Z. ges. exp. Med.143, 313 (1967).
Pichlmayr, R., W. Brendel, andR. Zenker: Production and effect of heterologous anticanine lymphocyte serum. Surgery61, 774 (1967).
Pichlmayr, R., W. Brendel, G. Beck, E. Schmittdiel, G. Tidow u.I. Pichlmayr: Herstellung heterologer Immunseren gegen Lymphozyten des Hundes. Klin. Wschr.45, 199 (1967).
Pichlmayr, R., W. Brendel, A. Fateh-Moghadam, I. Pichlmayr, S. Thierfelder, E. Bock, Gg. Beck, E. Schmittdiel, E. Wagner, K. Dobbelstein, andM. Knedel: Antilymphocyte serum and kidney transplantation. Symposium on „Cell-bound Immunity“, Liège 1967 (in press).
Pichlmayr, R., W. Brendel, Ph. Mikaeloff, B. Wiebecke, J. P. Rassat, I. Pichlmayr, J. Bomel, A. Fateh-Moghadam, S. Thierfelder, K. Messmer, J. Descotes, andM. Knedel: Survival of renal and liver homografts in dogs treated with heterologous antilymphocyte serum. I. Int. Congr. of the Transplantation Society. Paris 1967. Progr. Transplantation (1967) (in press).
Pichlmayr, R.,W. Brendel,S. Thierfelder,Gg. Beck,E. Schmittdiel, andE. Bock: Problems in the production of anti-human-lymphocyte-sera. II. Kongr. der Europ. Ges. für exp. Chirurgie, Löwen 1967, Excerpta med. (Amst.), Sect. internat. Congress-series (1967) (in press).
Pichlmayr, R., W. Brendel, A. Tsirimbas, E. Bock, S. Thierfelder, A. Fateh-Moghadam, B. Hornung, andH. Pfisterer: Use of heterologous antilymphocytesera in man. XXII. Congr. der Soc. Int. de Chirurgie, Wien 1967 (in press).
Pichlmayr, R.: Unveröffentlichte Untersuchungen.
Riethmueller, G., P. Rieber, andD. Riethmueller: Effect of intact and of pepsin-digested anti-mouse-γ G on antibody forming spleen cells and on the homograft reaction. I. Int. Congr. of the Transplantation Society Paris 1967. Progr. Transplantation (1967) (in press).
Rood, J. van, u.R. Pichlmayr: In Vorbereitung.
Starzl, Th. E., Th. L. Marchioro, K. A. Porter, Y. Iwasaki, andG. J. Cerilli: The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg. Gynaec. Obstet.124, 301 (1967).
Starzl, Th. E., K. A. Porter, Y. Iwasaki, Th. L. Marchioro, andN. Kashiwagi: The use of heterologous antilymphocyte globulin in human renal homotransplantation. In:G. E. W. Wolstenholme, andM. O'Connor, Antilymphocytie serum, Ciba Foundation Study Group No. 29, p. 4. London: Churchill 1967.
Starzl, Th. E.: Discussion in:G. E. W. Wolstenholme andM. O'Connor: Antilymphocytic serum, Ciba Foundation Study Group No. 29, p. 141. London: Churchill 1967.
Starzl, Th. E.: Round table on human antilymphocyte serum, Paris 1967 (in press).
Thierfelder, S., D. Moeller, J. Kimura, P. Doermer, M. Eulitz u.W. Mempel: Die Wirkung von heterologem Antilymphozytenserum auf die homologe und heterologe Knochenmarksübertragung bei supraletal bestrahlten Mäusen. Blut15, 225 (1967).
Thierfelder, S., D. Moeller, P. Doermer, M. Eulitz u.J. Kimura: Die Zellspezifität heterologer sogenannter antilymphocytärer Antiseren vom Kaninchen. Z. ges. exp. Med. (1967) (im Durck).
Traeger, J.: Préparation, propriétés et activités d'un sérum antilymphocyte humain. Symposion on „Cell-Bound Immunity“, Liège 1967 (in press).
Trepel, F., R. Pichlmayr, H. Begemann u.W. Brendel: Behandlungs-versuch menschlicher Autoaggressionskrankheiten mit Antilymphocytenserum. Klin. Wschr.46, im Druck (1968).
Tsirimbas, A., R. Pichlmayr, B. Hornung, H. Peisterer, S. Thierfelder, W. Brendel u.W. Stich: Therapieversuch mit heterologem Antihumanlymphozytenserum (AHLS) bei Patienten mit chronischer Lymphadenose. Klin. Wschr. (1967) (im Druck).
Tsirimbas, A., u.S. Hasslinger: In Vorbereitung.
Waksman, B. H., S. Arbouys, andB. G. Arnason: Use of specific “lymphocyte” antisera to inhibit hypersensitive reactions of “delayed” type. J. exp. Med.114, 997 (1961).
Werner, B.: Thoracic duct cannulation in man. Acta chir. scand., Suppl. 353 (1965).
Wolstenholme, G. E. W., andM. O'Connor: Antilymphocyte serum, Ciba Foundation Study Group No. 29. London: Churchill 1967.
Woodruff, M. F. A., andN. A. Anderson: Effect of lymphocyte depletion by thoracic duct fistula and administration of antilymphocytic serum on the survival of skin homografts in rats. Nature (Lond.)200, 702 (1963).
Woodruff, M. F. A., B. Reid, andK. James: Effect of antilymphocytic antibody and antibody fragments on human lymphocytes in vitro. Nature (Lond.)215, 591 (1967).
Woodruff, M. F. A., K. James, N. F. Anderson, andB. L. Reid: In vivo and in vitro properties of antilymphocytic serum. In:G. E. W. Wolstenholme andM. O'Connor, Antilymphocyte serum, Ciba Foundation Study Group No. 29, p. 57. London: Churchill 1967.
Woodruff, M. F. A.: Discussion in:G. E. W. Wolstenholme andM. O'Connor, Antilymphocyte serum, Ciba Foundation Study Group No. 29, p. 141. London: Churchill 1967.
Woodruff, M. F. A.: Round table on human antilymphocyte serum, Paris 1967 (in press).
Author information
Authors and Affiliations
Additional information
Herrn Professor Dr. med. Dr. med. h. c.R. Zenker zum 65. Geburtstag gewidmet.
Rights and permissions
About this article
Cite this article
Pichlmayr, R., Brendel, W., Beck, G. et al. Gewinnung von heterologen Immunseren gegen menschliche Lymphocyten. Klin Wochenschr 46, 249–258 (1968). https://doi.org/10.1007/BF01770881
Issue Date:
DOI: https://doi.org/10.1007/BF01770881